You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Symptomatic use of beclomethasone-albuterol and regular use of beclomethasone did not differ for control of mild asthma

https://doi.org/10.1136/ebm.12.6.173

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In patients with mild, persistent asthma, is symptomatic use of beclomethasone-albuterol in combination as effective as regular use of the same dose of beclomethasone and superior to symptomatic use of albuterol for controlling asthma?

    Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356:2040–52.

    Clinical impact ratings Internal medicine ★★★★★★★ Respirology ★★★★★★★ Allergy & immunology ★★★★★★⋆

    METHODS

    Embedded ImageDesign:

    randomised controlled trial (Beclomethasone plus Salbutamol Treatment [BEST] study).

    Embedded ImageAllocation:

    unclear allocation concealment.*

    Embedded ImageBlinding:

    blinded (unclear).*

    Embedded ImageFollow-up period:

    6 months.

    Embedded ImageSetting:

    25 centres in Italy, Austria, Poland, and Spain.

    Embedded ImagePatients:

    466 patients, 18–65 years of age, with mild, persistent asthma for ⩾6 months, prebronchodilator FEV1 ⩾75% of predicted value, and controlled asthma during …

    View Full Text

    Footnotes

    • Source of funding: Chiesi Farmaceutici.